Table 1.
Type of Study (no. of articles) | Positive Primary End Point | Reporting Bias Present | Spin Present | Article Presented as Positive |
Duration of untreated psychosis (6)b | 1 (17) [0.4–64.1] | 3 (50) [11.8–88.1] | 5 (83) [35.8–99.6] | 5 (83) [35.8–99.6] |
Ultra-high risk of psychosis (13)c | 2 (15) [1.9–45.4] | 6 (46) [19.2–74.9] | 8 (62) [31.6–86.1] | 9 (69) [38.6–90.9] |
Early intervention in psychosis (19)d | 2 (11) [1.3–33.1] | 13 (68) [43.4–87.4] | 12 (63) [38.4–83.7] | 15 (79) [54.4–93.9] |
Total (38) | 5 (13) [4.4–28.1] | 22 (58) [40.8–73.7] | 25 (66) [48.6–80.4] | 29 (76) [59.8–88.6] |
Values presented as number (%) of articles [95% CI].
Duration of untreated psychosis: quasi-experimental design comparing region with public health intervention to reduce the period of time spent between the onset of a psychotic illness and the initiation of treatment.
Ultra-high risk: randomized controlled trials comparing outcomes of patients at high risk of developing a long-term psychotic illness randomized to treatment as usual versus active interventions including antipsychotic medication, fatty acids, or cognitive-behavioral therapy.
Early intervention in psychosis: randomized controlled trials comparing outcomes in patients with first-episode psychosis randomized to treatment as usual versus early intensive treatment, with low patient to case manager ratios, family psychoeducation, and social skills training.